Inventor · disambiguated record
Pascal Furet
Also filed as: FURET PASCAL
97 granted patents·57 pending applications·1,548 citations·filing 1993–2024
99Inventor score
Top patents by PatentIndex Score
154 records- 0197US8815901B2Quinoline carboxamide derivatives as protein tyrosine kinase inhibitorsNOVARTIS AG·Filed 2013·Granted Aug 26, 2014·69 cites·9 claims
- 0297US8026247B2Bicyclic amides as kinase inhibitorsNOVARTIS AG·Filed 2005·Granted Sep 27, 2011·60 cites·3 claims
- 0397US7667039B21,3-dihydro-imidazo [4,5-C] quinolin-2-ones as lipid kinase inhibitorsNOVARTIS AG·Filed 2006·Granted Feb 23, 2010·90 cites·2 claims
- 0496US7169791B2Inhibitors of tyrosine kinasesNOVARTIS AG·Filed 2003·Granted Jan 30, 2007·102 cites·11 claims
- 0595US8552002B2Compounds and compositions as protein kinase inhibitorsDING QIANG·Filed 2005·Granted Oct 8, 2013·132 cites·43 claims
- 0695US8227462B2Pyrrolidine-1,2-dicarboxamide derivativesFAIRHURST ROBIN ALEC·Filed 2009·Granted Jul 24, 2012·28 cites·5 claims
- 0795US7795273B2Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitorsNOVARTIS AG·Filed 2006·Granted Sep 14, 2010·53 cites·6 claims
- 0895US6448277B2VEGF receptor tyrosine kinase inhibitorsNOVARTIS AG·Filed 2001·Granted Sep 10, 2002·64 cites·19 claims
- 0994US8759517B2Pyrirnidinyl aryl urea derivatives being FGF inhibitorsNOVARTIS AG·Filed 2012·Granted Jun 24, 2014·11 cites·1 claims
- 1094US8293746B2Pyrimidinyl aryl urea derivatives being FGF inhibitorsBOLD GUIDO·Filed 2006·Granted Oct 23, 2012·17 cites·5 claims
- 1194US6878720B2VEGF receptor tyrosine kinase inhibitorsNOVARTIS AG·Filed 2002·Granted Apr 12, 2005·50 cites·16 claims
- 1292US8476268B2Pyrrolidine-1,2-dicarboxamide derivativesFAIRHURST ROBIN ALEC·Filed 2012·Granted Jul 2, 2013·17 cites·5 claims
- 1392US5686457APyrrolopyrimidine derivatives having pharmacological activityNOVARTIS AG·Filed 1995·Granted Nov 11, 1997·92 cites·2 claims
- 1491US9533988B2Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsBUSCHMANN NICOLE·Filed 2015·Granted Jan 3, 2017·13 cites·8 claims
- 1590US9266883B2Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsBUSCHMANN NICOLE·Filed 2014·Granted Feb 23, 2016·16 cites·13 claims
- 1690US8969341B2Pyrazolopyrrolidine compoundsFURET PASCAL·Filed 2012·Granted Mar 3, 2015·8 cites·13 claims
- 1790US8431592B21,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase inhibitorsGARCIA-ECHEVERRIA CARLOS·Filed 2011·Granted Apr 30, 2013·13 cites·5 claims
- 1890US7994170B21,3-dihydro-imidazo[4,5-C]quinolin-2-ones as lipid kinase inhibitorsNOVARTIS AG·Filed 2009·Granted Aug 9, 2011·12 cites·5 claims
- 1990US7569566B2Inhibitors of tyrosine kinasesNOVARTIS AG·Filed 2008·Granted Aug 4, 2009·11 cites·7 claims
- 2090US7083983B2Inhibitors of the interaction between P53 and MDM2CANCER RES CAMPAIGN TECH·Filed 1997·Granted Aug 1, 2006·108 cites·15 claims
- 2190US5981533APyrazole derivatives and processes for the preparation thereofNOVARTIS AG·Filed 1996·Granted Nov 9, 1999·104 cites·12 claims
- 2289US7002022B2N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGFSCHERING AG·Filed 2004·Granted Feb 21, 2006·24 cites·8 claims
- 2387US8710085B2Pyrrolidine-1,2-dicarboxamide derivativesGUAGNANO VITO·Filed 2013·Granted Apr 29, 2014·11 cites·2 claims
- 2487US7326699B24-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivativesNOVARTIS AG·Filed 2002·Granted Feb 5, 2008·28 cites·9 claims
- 2587US5332729AN-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acidsCIBA GEIGY CORP·Filed 1993·Granted Jul 26, 1994·29 cites·19 claims
- 2686US8865894B2Oxazolidin-2-one compounds and uses thereofNOVARTIS AG·Filed 2013·Granted Oct 21, 2014·10 cites·22 claims
- 2786US8829195B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1DODD STEPHANIE KAY·Filed 2013·Granted Sep 9, 2014·16 cites·16 claims
- 2886US7855215B2Cyclic diaryl ureas suitable as tyrosine kinase inhibitorsNOVARTIS AG·Filed 2005·Granted Dec 21, 2010·6 cites·19 claims
- 2986US7122547B1Anthranilic acid amides and the use thereof as medicamentsNOVARTIS AG·Filed 1999·Granted Oct 17, 2006·79 cites·14 claims
- 3085US9763952B2Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivativesCARAVATTI GIORGIO·Filed 2015·Granted Sep 19, 2017·9 cites·10 claims
- 3185US9340537B2Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2013·Granted May 17, 2016·4 cites·3 claims
- 3285US9278981B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2013·Granted Mar 8, 2016·6 cites·18 claims
- 3385US8815926B2Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseasesNOVARTIS AG·Filed 2013·Granted Aug 26, 2014·8 cites·25 claims
- 3485US8440693B2Substituted isoquinolinones and quinazolinonesBERGHAUSEN JOERG·Filed 2010·Granted May 14, 2013·14 cites·15 claims
- 3585US7956053B2Inhibitors of tyrosine kinasesNOVARTIS AG·Filed 2009·Granted Jun 7, 2011·5 cites·7 claims
- 3684US8389526B23-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivativesFURET PASCAL·Filed 2010·Granted Mar 5, 2013·4 cites·9 claims
- 3782US7652022B2Diaryl urea derivatives useful for the treatment of protein kinase dependent diseasesNOVARTIS AG·Filed 2003·Granted Jan 26, 2010·21 cites·9 claims
- 3882US7189729B2Methods and compositions as protein kinase inhibitorsIRM LLC·Filed 2004·Granted Mar 13, 2007·18 cites·7 claims
- 3981US9949979B2Use of inhibitors of the activity or function of PI3KNOVARTIS AG·Filed 2012·Granted Apr 24, 2018·9 cites·9 claims
- 4081US7592349B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2007·Granted Sep 22, 2009·3 cites·14 claims
- 4181US7563894B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2007·Granted Jul 21, 2009·3 cites·10 claims
- 4280US6096749APyrrolopyrimidine derivatives having pharmacological activityNOVARTIS AG·Filed 1998·Granted Aug 1, 2000·42 cites·10 claims
- 4379US6767906B22-amino-6-anilino-purines and their use as medicamentsNOVARTIS AG·Filed 2001·Granted Jul 27, 2004·14 cites·15 claims
- 4478US10130629B2Pharmaceutical combinationsNOVARTIS AG·Filed 2016·Granted Nov 20, 2018·3 cites·7 claims
- 4578US9896449B2Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsBUSCHMANN NICOLE·Filed 2016·Granted Feb 20, 2018·2 cites·1 claims
- 4678US9802917B2Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamideBUSCHMANN NICOLE·Filed 2016·Granted Oct 31, 2017·2 cites·15 claims
- 4778US8476294B21H-imidazo[4,5-c]quinolinone derivativesFURET PASCAL·Filed 2010·Granted Jul 2, 2013·5 cites·3 claims
- 4878US7514447B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2006·Granted Apr 7, 2009·2 cites·6 claims
- 4977US10059709B2CompoundsELANCO TIERGESUNDHEIT AG·Filed 2015·Granted Aug 28, 2018·2 cites·5 claims
- 5077US8030311B2Phenylacetamides suitable as protein kinase inhibitorsNOVARTIS AG·Filed 2006·Granted Oct 4, 2011·2 cites·10 claims
Showing the top 50 of 154 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Pascal Furet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →